肠道微生态与酒精性肝病

李炜; 邢卉春

doi:10.3969/j.issn.1001-5256.2019.03.006

肠道微生态与酒精性肝病

DOI: 10.3969/j.issn.1001-5256.2019.03.006

李炜,
邢卉春

首都医科大学附属北京地坛医院肝病三科

基金项目:

北京市医院管理局扬帆计划(xmlx201837)；十三五艾滋病和病毒性肝炎等重大传染病防治(2018ZX10302206-003-006)；吴阶平医学基金会(LDWJPMF-103-17001)；首都医科大学附属北京地坛医院院内科研基金“育苗计划”项目(DTYM201605)；

详细信息

中图分类号: R575
计量
- 文章访问数: 1458
- HTML全文浏览量: 37
- PDF下载量: 442
- 被引次数: 0
出版历程
- 出版日期: 2019-03-20

Intestinal microflora and alcoholic liver disease

Third Department of Hepatology, Beijing Ditan Hospital, Capital Medical University

Research funding:

摘要

摘要:
肠道正常菌群及其所构成的微生态是人体正常生理功能所必需。酒精性肝病时存在肠道微生态失衡,表现为菌群数量、构成比的紊乱,肠黏膜屏障功能破坏、细菌易位及肠源性内毒素血症等,在酒精性肝病的发生发展中具有重要作用。同时肠道菌群对酒精的代谢也有重要影响。益生菌制剂或粪菌移植调整肠道微生态有望对酒精性肝病产生积极的治疗作用。在酒精性肝病的防治中,如何规范使用微生态制剂、选择合适的剂量、剂型及疗程等均值得进一步探讨。
- 肝疾病,酒精性 /
- 肠杆菌科
Abstract:
Normal intestinal microflora and microecology are essential for normal physiological functions in human body. Intestinal microfloraimbalance is often observed in patients with alcoholic liver disease and manifests as abnormal number and constituent ratio of intestinal micro-flora, dysfunction of intestinal mucosal barrier, bacterial translocation, and intestinal endotoxemia, and it plays an important role in the de-velopment and progression of alcoholic liver disease. In addition, intestinal microflora also has influence on alcohol metabolism. Probiotics orfecal microbiota transplantation can regulate intestinal microflora and may play an active role in the treatment of alcoholic liver disease. Fur-ther studies are needed to discuss the standardized use of microecologics, dose selection, dosage form, and course of treatment during theprevention and treatment of alcoholic liver disease.
- liver diseases, alcoholic /
- enterobacteriaceae

HTML全文

参考文献(31)

[1] YOUNOSSI Z, HENRY L. Contribution of alcoholic and nonal-coholic fatty liver disease to the burden of liver related morbidi-ty and mortality[J]. Gastroenterology, 2016, 150 (8) :1778-1785.

[2] National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association;Fatty Liver Expert Committee, Chinese Medical Doctor Associ-ation. Guidelines of prevention and treatment for nonalcoholicfatty liver disease:A 2018 update[J]. J Clin Hepatol, 2018, 34 (5) :947-957. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南 (2018年更新版) [J].临床肝胆病杂志, 2018, 34 (5) :947-957.

[3] WINSTON D, VIJAY HS. Pathogenesis of alocholic liver dis-ease[J]. Clin Liver Dis, 2016, 20 (3) :445-456.

[4] BODE JC, BODE C, HEIDELBACH R, et al. Microflora in pa-tients with chronic alcohol abuse[J]. Hepatogastroenterology, 1984, 31 (1) :30-34.

[5] CASAFONT MORENCOS F, de LAS HERAS CASTAO G, MARTNRAMOS L, et al. Smal bowel bacterial overgrowth in patients withalcoholic cirrhosis[J]. Dig Dis Sci, 1996, 41 (3) :552-556.

[6] GABBARD SL, LACY BE, LEVINE GM, et al. The impact of al-cohol consumption and cholecystectomy on small intestinalbacterial overgrowth[J]. Dig Dis Sci, 2014, 59 (3) :638-644.

[7] BULL-OTTERSON L, FENG W, KIRPICH I, et al. Metagenomicanalyses of alcohol induced pathogenic alterations in the intestinalmicrobiome and the effect of Lactobacillus rhamnosus GG treat-ment[J]. PLo S One, 2013, 8 (1) :e53028.

[8] VISAPJP, TILLONEN J, SALASPURO M. Microbes and muco-sa in the regulation of intracolonic acetaldehyde concentrationduring ethanol challenge[J]. Alcohol Alcohol, 2002, 37 (4) :322-326.

[9] MUTLU EA, GILLEVET PM, RANGWALA H, et al. Colonic mi-crobiome is altered in alcoholism[J]. Am J Physiol Gastroint-est Liver Physiol, 2012, 302 (9) :g966-g978.

[10] YANG AM, INAMINE T, HOCHRATH K, et al. Intestinal fungicontribute to development of alcoholic liver disease[J]. J ClinInvest, 2017, 127 (7) :2829-2841.

[11] ENGEN PA, GREEN SJ, VOIGT RM, et al. The gastrointesti-nal microbiome:Alcohol effects on the composition of intestinalmicrobiota[J]. Alcohol Res, 2015, 37 (2) :223-236.

[12] SOKOL H, PIGNEUR B, WATTERLOT L, et al. Faecalibacteri-um prausnitzii is an anti-inflammatory commensal bacterium i-dentified by gut microbiota analysis of Crohn disease patients[J]. Proc Natl Acad Sci U S A, 2008, 105 (43) :16731-16736.

[13] BAJAJ JS, HEUMAN DM, HYLEMON PB, et al. Altered profileof human gut microbiome is associated with cirrhosis and itscomplications[J]. J Hepatol, 2014, 60 (5) :940-947.

[14] YAN AW, FOUTS DE, BRANDL J, et al. Enteric dysbiosis as-sociated with a mouse model of alcoholic liver disease[J].Hepatology, 2011, 53 (1) :96-105.

[15] LIPPAI D, BALA S, CATALANO D, et al. MicroRNA-155 de-ficiency prevents alcohol-induced serum endotoxin increaseand small bowel inflammation in mice[J]. Alcohol Clin ExpRes, 2014, 38 (8) :2217-2224.

[16] WANG Y, TONG J, CHANG B, et al. Effects of alcohol on in-testinal epithelial barrier permeability and expression of tightjunction associated proteins[J]. Mol Med Rep, 2014, 9 (6) :2352-2356.

[17] WANG L, FOUTS DE, STRKEL P, et al. Intestinal REG3 lec-tins protect against alcoholic steatohepatitis by reducing mu-cosa-associated microbiota and preventing bacterial translo-cation[J]. Cell Host Microbe, 2016, 19 (2) :227-239.

[18] LLOPIS M, CASSARD AM, WRZOSEK L, et al. Intestinal mi-crobiota contributes to individual susceptibility to alcoholic liverdisease[J]. Gut, 2016, 65 (5) :830-839.

[19] FERRERE G, WRZOSEK L, CAILLEUX F, et al. Fecal microbi-ota manipulation prevents dysbiosis and alcohol-induced liverinjury in mice[J]. J Hepatol, 2017, 66 (4) :806-815.

[20] TILLONEN J, VKEVINEN S, SALASPURO V, et al. Metron-idazole increases intracolonic but not peripheral blood acetal-dehyde in chronic ethanol-treated rats[J]. Alcohol Clin ExpRes, 2000, 24 (4) :570-575.

[21] SINGH R, BULLARD J, KALRA M, et al. Status of bacterial colo-nization, Toll-like receptor expression and nuclear factor-kappaB activation in normal and diseased human livers[J]. Clin Immu-nol, 2011, 138 (1) :41-49.

[22] PUROHIT V, BODE JC, BODE C, et al. Alcohol, intestinal bacteri-al growth, intestinal permeability to endotoxin, and medical con-sequences:Summary of a symposium[J]. Alcohol, 2008, 42 (5) :349-361.

[23] ROH YS, ZHANG B, LOOMBA R, et al. TLR2 and TLR9 con-tribute to alcohol-mediated liver injury through induction ofCXCL1 and neutro-phil infiltration[J]. Am J Physiol Gastroi-ntest Liver Physiol, 2015, 309 (1) :g30-g41.

[24] QIN N, YANG F, LI A, et al. Alterations of the human gut micro-biome in liver cirrhosis[J]. Nature, 2014, 513 (7516) :59-64.

[25] NANJI AA, KHETTRY U, SADRZADEH SM. Lactobacillus feedingreduces endotoxemia and severity of experimental alcoholic liver (disease) [J]. Proc Soc Exp Biol Med, 1994, 205 (3) :243-247.

[26] KIRPICH IA, SOLOVIEVA NV, LEIKHTER SN, et al. Probioticsrestore bowel flora and improve liver enzymes in human alco-hol-induced liver injury:A pilot study[J]. Alcohol, 2008, 42 (8) :675-682.

[27] STADLBAUER V, MOOKERJEE RP, HODGES S, et al. Effectof probiotic treatment on deranged neutrophil function and cy-tokine responses in patients with compensated alcoholic cir-rhosis[J]. J Hepatol, 2008, 48 (6) :945-951.

[28] KALMAN RS, GOLDBERG DS. The role of obeticholic acid ingut bacterial translocation and inflammation[J]. Gastroenter-ology, 2016, 151 (4) :759-761.

[29] WOODHOUSE CA, PATEL VC, SINGANAYAGAM A, et al.Review article:The gut microbiome as a therapeutic target inthe pathogenesis and treatment of chronic liver disease[J].Aliment Pharmacol Ther, 2018, 47 (2) :192-202.

[30] BAJAJ JS, KASSAM Z, FAGAN A, et al. Fecal microbiotatransplant from a rational stool donor improves hepatic en-cephalopathy:A randomized clinical trial[J]. Hepatology, 2017, 66 (6) :1727-1738.

[31] XING HC, LI LJ, XU KJ, et al. Protective role of supplementwith foreign Bifidobacterium and Lactobacillus in experimentalhepatic ischemia-reperfusion injury[J]. J Gastroenterol Hep-atol, 2006, 21 (4) :647-656.

施引文献

资源附件(0)

访问统计